Previous studies have shown that MYC can bind directly to the promoter of PD-L1 gene, while PD-L1 can inhibit T cell responses in the tumor microenvironment, and further found that MYC inactivation in mouse tumors can down-regulate the expression of PD-L1 and enhance anti-tumor immune responses. This evidence concerns the gene MYC and neoplasm.